Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Role of favipiravir in the treatment of adult patients with moderate to severe COVID-19: a single-center, prospective, observational, sequential cohort study from Hungary

Balint Gergely Szabo, Katalin Szidonia Lenart, Borisz Petrik, Zsofia Gaspar, Zsofia Balogh, Zsuzsanna Banyai, Emese Banyasz, Jozsef Budai, Eszter Czel, Katalin Fried, Adrienn Hanuska, Noemi Kiss-Dala, Csaba Lorinczi, Krisztina Nemesi, Janos Kadar, Eva Livia Nagy, Akos Osvald, Edina Petrovicz, Alexandra Riczu, Judit Szanka, Beata Szathmary, Andrea Szombati, Szilvia Toth, Zsuzsanna Varnai, Orsolya Woller, Janos Szlavik, Botond Lakatos
doi: https://doi.org/10.1101/2020.11.26.20238014
Balint Gergely Szabo
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
2Semmelweis University, School of PhD Studies (H-1085 Ulloi ut 26., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: szabo.balint.gergely@gmail.com
Katalin Szidonia Lenart
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Borisz Petrik
3Semmelweis University, Faculty of Medicine (H-1085 Ulloi ut 26., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsofia Gaspar
3Semmelweis University, Faculty of Medicine (H-1085 Ulloi ut 26., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsofia Balogh
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsuzsanna Banyai
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emese Banyasz
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jozsef Budai
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eszter Czel
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katalin Fried
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienn Hanuska
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noemi Kiss-Dala
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Csaba Lorinczi
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krisztina Nemesi
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janos Kadar
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Livia Nagy
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akos Osvald
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edina Petrovicz
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Riczu
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judit Szanka
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beata Szathmary
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Szombati
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Szilvia Toth
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsuzsanna Varnai
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orsolya Woller
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janos Szlavik
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Botond Lakatos
1South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus (H-1097 Albert Florian ut 5-7., Budapest, Hungary)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Preliminary data suggests that favipiravir might have a role in COVID-19 treatment. Our aim was to assess the role of favipiravir in the treatment of COVID-19.

Methods A single-center, prospective, observational, sequential cohort study was performed among consecutive adults hospitalized with PCR-confirmed COVID-19 between March– July,2020. Patients were screened for inclusion by a priori criteria, and were included in the favipiravir cohort if SOC+FVP, or the non-favipiravir group if SOC±other antiviral medications without FVP were administered for >48 hours. Treatment allocation was done per national guidelines. For COVID-19 diagnosis and severity, ECDC and WHO definitions were utilized, and daily per protocol hospital follow-up was done. Primary composite end-point was disease progression (14-day all-cause death, need for mechanical ventilation, or immunomodulatory therapy). For statistical comparison, Fisher’s exact test and Mann– Whitney U-test were used.

Results In all, 75 patients were included per cohort. In the FVP cohort, chronic heart disease (36/75, 48.0% vs. 16/75, 21.3%, p<0.01) and diabetes mellitus (23/75, 30.7% vs. 10/75, 13.3%, p<0.01) were more prevalent, hospital LOS (18.5±15.5 days vs. 13.0±8.5 days, p<0.01) was higher. Disease progression (17/75, 22.7% vs. 10/75, 13.3%, p=0.13), 14-day all-cause death (9/75, 12.0% vs. 10/75, 13.3%, p=0.8) and need for mechanical ventillation (8/75, 10.7% vs. 4/75, 5.3%, p=0.22) were similar between groups. Immunomodulatory therapies were administered frequently among patients receiving FVP (10/75, 13.3% vs. 1/75, 1.3%, p<0.01).

Conclusions In this study, favipiravir did not seem to affect disease progression. Further data are needed to position this drug among the anti-SARS-CoV-2 armamentarium.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The article itself did not receive any external funding. BGSz received the EFOP-3.6.3-VEKOP-16-2017-00009 Doctorate Grant, and was supported by the UNKP-19-3-I-SE-74 New National Excellence Program of the Ministry of Innovation and Technology of Hungary. The funding sources had no involvement in the preparation, writing, interpretation, or submission of this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Review Board of South Pest Central Hospital, National Institute of Hematology and Infectious Diseases (Budapest, Hungary) approved the study protocol. Approval for the use of off-label investigational drugs was granted by our institutional review board, as well as the National Institute of Pharmacy and Nutrition in relation to the COVID-19 surge in Hungary (ogyei.gov.hu/tajekoztato_a_veszelyhelyzet_megszunesevel_kapcsolatos_a_covid_19_jarvany_idejen_kulonos_meltanylast_erdemlo_betegellatasi_erdekhez_kotheto_gyogyszeralkalmazasok_bejelenteserol).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Anonymised data of patients are available from the corresponding author on reasonable request.

  • ABBREVIATIONS

    ARDS
    acute respiratory distress syndrome
    BAL
    bronchoalveolar lavage
    COVID-19
    coronavirus disease-19
    CRP
    C-reactive protein
    CS
    cytokine storm
    CT
    computed tomography
    ECDC
    European Centre for Disease Prevention and Control
    EUCAST
    European Committee on Antimicrobial Susceptibility Testing
    FVP
    favipiravir
    ICU
    intensive care unit
    IQR
    interquartile region
    LDH
    lactate dehydrogenase
    LOS
    length of stay
    PCR
    polymerase chain reaction
    RCT
    randomized clinical trials
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus-2
    SOC
    standard of care
    STROBE
    Strengthening the Reporting of Observational studies in Epidemiology
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted December 09, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Role of favipiravir in the treatment of adult patients with moderate to severe COVID-19: a single-center, prospective, observational, sequential cohort study from Hungary
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Role of favipiravir in the treatment of adult patients with moderate to severe COVID-19: a single-center, prospective, observational, sequential cohort study from Hungary
    Balint Gergely Szabo, Katalin Szidonia Lenart, Borisz Petrik, Zsofia Gaspar, Zsofia Balogh, Zsuzsanna Banyai, Emese Banyasz, Jozsef Budai, Eszter Czel, Katalin Fried, Adrienn Hanuska, Noemi Kiss-Dala, Csaba Lorinczi, Krisztina Nemesi, Janos Kadar, Eva Livia Nagy, Akos Osvald, Edina Petrovicz, Alexandra Riczu, Judit Szanka, Beata Szathmary, Andrea Szombati, Szilvia Toth, Zsuzsanna Varnai, Orsolya Woller, Janos Szlavik, Botond Lakatos
    medRxiv 2020.11.26.20238014; doi: https://doi.org/10.1101/2020.11.26.20238014
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Role of favipiravir in the treatment of adult patients with moderate to severe COVID-19: a single-center, prospective, observational, sequential cohort study from Hungary
    Balint Gergely Szabo, Katalin Szidonia Lenart, Borisz Petrik, Zsofia Gaspar, Zsofia Balogh, Zsuzsanna Banyai, Emese Banyasz, Jozsef Budai, Eszter Czel, Katalin Fried, Adrienn Hanuska, Noemi Kiss-Dala, Csaba Lorinczi, Krisztina Nemesi, Janos Kadar, Eva Livia Nagy, Akos Osvald, Edina Petrovicz, Alexandra Riczu, Judit Szanka, Beata Szathmary, Andrea Szombati, Szilvia Toth, Zsuzsanna Varnai, Orsolya Woller, Janos Szlavik, Botond Lakatos
    medRxiv 2020.11.26.20238014; doi: https://doi.org/10.1101/2020.11.26.20238014

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (175)
    • Allergy and Immunology (421)
    • Anesthesia (97)
    • Cardiovascular Medicine (901)
    • Dentistry and Oral Medicine (171)
    • Dermatology (102)
    • Emergency Medicine (257)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
    • Epidemiology (8796)
    • Forensic Medicine (4)
    • Gastroenterology (405)
    • Genetic and Genomic Medicine (1864)
    • Geriatric Medicine (179)
    • Health Economics (388)
    • Health Informatics (1292)
    • Health Policy (644)
    • Health Systems and Quality Improvement (493)
    • Hematology (207)
    • HIV/AIDS (396)
    • Infectious Diseases (except HIV/AIDS) (10577)
    • Intensive Care and Critical Care Medicine (564)
    • Medical Education (193)
    • Medical Ethics (52)
    • Nephrology (218)
    • Neurology (1762)
    • Nursing (104)
    • Nutrition (267)
    • Obstetrics and Gynecology (343)
    • Occupational and Environmental Health (461)
    • Oncology (966)
    • Ophthalmology (283)
    • Orthopedics (107)
    • Otolaryngology (177)
    • Pain Medicine (118)
    • Palliative Medicine (43)
    • Pathology (265)
    • Pediatrics (557)
    • Pharmacology and Therapeutics (266)
    • Primary Care Research (221)
    • Psychiatry and Clinical Psychology (1846)
    • Public and Global Health (3992)
    • Radiology and Imaging (655)
    • Rehabilitation Medicine and Physical Therapy (344)
    • Respiratory Medicine (536)
    • Rheumatology (216)
    • Sexual and Reproductive Health (178)
    • Sports Medicine (166)
    • Surgery (197)
    • Toxicology (37)
    • Transplantation (107)
    • Urology (80)